Qi Guo
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- CRISPR and Genetic Engineering
- RNA modifications and cancer
Papers in ⓘ
-
- CRISPR and Genetic Engineering 5
- Circular RNAs in diseases 5
- Planarian Biology and Electrostimulation 5
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 8
- Co-authors
- Charles Tilford (2 shared papers)Paul D.P. Pharoah (3 shared papers)Gabe Mintier (2 shared papers)John N. Feder (2 shared papers)Judith Wardwell-Swanson (1 shared paper)Zhaoliang Su (3 shared papers)Hong Xiao (1 shared paper)Jay A. Markwalder (1 shared paper)
- Journals
- Frontiers in Genetics (3 papers)Clinical Cancer Research (2 papers)Scientific Reports (2 papers)BMJ Paediatrics Open (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qi Guo
56 papers receiving 877 citations
Peers
Comparison fields: 5 of 110
- Cancer Research 190
- Molecular Biology 483
- Oncology 169
- Cell Biology 77
- Business and International Management 9
Countries citing papers authored by Qi Guo
This map shows the geographic impact of Qi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Guo more than expected).
Fields of papers citing papers by Qi Guo
This network shows the impact of papers produced by Qi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Guo. The network helps show where Qi Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 102 | |
| 2 | 2014 | 82 | |
| 3 | 2013 | 48 | |
| 4 | 2018 | 44 | |
| 5 | 2016 | 43 | |
| 6 | 2014 | 41 | |
| 7 | 2014 | 38 | |
| 8 | 2020 | 37 | |
| 9 | 2021 | 37 | |
| 10 | 2019 | 35 | |
| 11 | 2017 | 32 | |
| 12 | 2014 | 30 | |
| 13 | MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19. | 2015 | 29 |
| 14 | 2018 | 21 | |
| 15 | 2021 | 21 | |
| 16 | 2016 | 19 | |
| 17 | 2017 | 19 | |
| 18 | 2022 | 19 | |
| 19 | 2005 | 16 | |
| 20 | 2021 | 16 |
About Qi Guo
Qi Guo is a scholar working on Molecular Biology, Cancer Research, Genetics, Physiology and Oncology, having authored 61 papers that have together received 887 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (8 papers), CRISPR and Genetic Engineering (5 papers), Circular RNAs in diseases (5 papers), Marine Ecology and Invasive Species (5 papers), Planarian Biology and Electrostimulation (5 papers), Genetic Associations and Epidemiology (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Cancer Research (190 citations), Molecular Biology (483 citations), Oncology (169 citations), Cell Biology (77 citations) and Business and International Management (9 citations). Qi Guo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Charles Tilford, Paul D.P. Pharoah, Gabe Mintier, John N. Feder, Judith Wardwell-Swanson, Zhaoliang Su, Hong Xiao, Jay A. Markwalder, Tai-An Lin and Becky Penhallow. Their work appears in journals such as Frontiers in Genetics, Clinical Cancer Research, Scientific Reports, BMJ Paediatrics Open and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.